Researcher Bios

Learn more about the backgrounds, scientific pursuits and personal interests of the members of our research team. These individuals are committed to pursuing Bristol-Myers Squibb’s goal of discovering, developing and delivering transformational medicines to patients.
Benjamin Soule, M.D.
Benjamin Soule, M.D.

Fibrosis Clinical Development Lead

Edgar Charles, M.D.
Edgar Charles, M.D.

Clinical Development Lead, pegylated FGF21

John Throup, BSc, Ph.D.
John Throup, BSc, Ph.D.

Development Lead, Immunoscience R&D

Sara Baletsa
Sara Balesta

R&D Learning Practice Lead, R&D Strategy and Planning

Charlotte Jones-Burton
Charlotte Jones-Burton, M.D., M.S.

Global Clinical Program Lead, Cardiovascular Marketed Products

Mark Selby
Mark Selby, Ph.D.

Senior Director, Immuno-oncology Discovery

Rehbar Tayyabkhan
Rehbar (Reb) Tayyabkhan

Head of Global Data Strategy and Solutions, Global Clinical Operations

Alan Korman
Alan Korman, Ph.D.

Vice President, Immuno-Oncology Discovery

Binodh DeSilva
Binodh DeSilva, Ph.D.

Head of Analytical and Bioanalytical Operations, Pharmaceutical Development

Luisa Salter-Cid
Luisa Salter-Cid, Ph.D.

Head of Immunology Discovery, Biology and Genomics

Percy Carter
Percy Carter, MBA, Ph.D.

Head of Discovery Chemistry and Molecular Technologies, Drug Discovery Research

Evan Janovitz
Evan Janovitz, DVM, Ph.D., DACVP

Director of Pathology, Discovery Toxicology